Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib exposure and early metabolic response in soft tissue sarcoma
2013-003533-16Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pazopanib in soft tissue sarcoma (STS), sponsored by Radboud University Medical Center. Primary endpoints: Progression-free survival by degree of early metabolic response and Pazopanib exposure by age group. Started Sep 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2013-003533-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003533-16.